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Abstract
Early detection of cancer-associated genomic instability is crucial, particularly in tumour types in which this instability
represents the essential underlying mechanism of tumourigenesis. Currently used methods require the presence of already
established neoplastic cells because they only detect clonal mutations. In principle, parallel sequencing of single DNA
filaments could reveal the early phases of tumour initiation by detecting low-frequency mutations, provided an adequate
depth of coverage and an effective control of the experimental error. We applied ultradeep sequencing to estimate the
genomic instability of individuals with hereditary non-polyposis colorectal cancer (HNPCC). To overcome the experimental
error, we used an ultraconserved region (UCR) of the human genome as an internal control. By comparing the mutability
outside and inside the UCR, we observed a tendency of the ultraconserved element to accumulate significantly fewer
mutations than the flanking segments in both neoplastic and nonneoplastic HNPCC samples. No difference between the
two regions was detectable in cells from healthy donors, indicating that all three HNPCC samples have mutation rates
higher than the healthy genome. This is the first, to our knowledge, direct evidence of an intrinsic genomic instability of
individuals with heterozygous mutations in mismatch repair genes, and constitutes the proof of principle for the
development of a more sensitive molecular assay of genomic instability.
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Introduction
Genomic instability is a common trait of cancer cells and plays a
pivotal role in promoting carcinogenesis in several hereditary
tumours. One of the best-known examples is the Lynch syndrome,
an autosomal dominant condition associated with heterozygous
mutations in mismatch repair (MMR) genes [1]. During their
lifespan, individuals affected by the Lynch syndrome undergo
somatic inactivation of the second allele that causes the
impairment of the MMR machinery and the onset of the
‘‘mutator phenotype’’ [2]. The tumourigenic process starts when
mutations hit oncogenes and/or tumour suppressors, often in
actively renovating tissues such as endometrium, ovary, and colon.
In the latter case, the genetic condition is known as hereditary
non-polyposis colorectal cancer (HNPCC), which represents the
most common form of inherited colorectal cancer [3]. A hallmark
of MMR deficiency is microsatellite instability (MSI), which
measures the accumulation of insertions and deletions (indels) at
repeated regions of the genome. Since more than 90% of HNPCC
show MSI [4,5], this has become a common diagnostic marker of
MMR deficiency. Recently, large-scale mutational screenings
returned the first estimations of the mutation frequency, which is
the number of mutations per genome unit, associated with coding
and noncoding sequences of cancer genomes [6–9]. These studies
measured a higher proportion of base substitutions in MMR-
deficient compared to MMR-proficient cancers [6]. Both MSI and
large-scale mutational screenings only reveal mutations occurring
in most cancer cells, namely in an expanded clonal population,
while neglecting low-frequency substitutions. The returned picture
is a ‘‘static snapshot’’ of the cancer genome in which only the tip of
the iceberg (i.e., clonal mutations) is captured. The detection of
low-frequency mutations in addition to clonal mutations is
instrumental to clarify controversial aspects of cancer genetics.
For example, the high sensitivity needed to find nonclonal
mutations helps to trace the appearance of the mutator phenotype,
thus clarifying the role of genomic instability during the early
stages of carcinogenesis. So far, technical limitations prevented the
detection of low-frequency mutations, since traditional sequencing
procedures cannot reach the required level of sensitivity. In past
years, several approaches have been explored to overcome this
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principle, next-generation sequencing technologies could offer a
valid solution, as they rely on amplification and sequencing of
distinct DNA filaments. Because sensitivity of these methods
increases with coverage, rare mutations should become detectable
by performing an ultradeep resequencing of a given DNA region.
The obvious drawback is connected with specificity: at deep
coverage, low-frequency substitutions are an indistinguishable
mixture of technical errors and true mutations, which makes it
hard to distinguish true signal from noise. One possible solution to
overcome technical errors is to use internal controls, i.e., genomic
elements that do not accumulate true mutations so that all
substitutions observed in these regions are bona fide errors.
Ultraconserved regions (UCRs) of the human genome constitute a
possible repository of such immutable segments. UCRs are
genomic elements longer than 200 base pairs (bp), 100% identical
between human, mouse, and rat, and significantly depleted in
SNPs [12] and copy number variants [13] within the human
population. Although mice lacking UCRs are in general viable and
fertile [14], these regions undergo purifying selection [15] even
stronger than nonsynonymous sites [16]. UCRs seem to have ideal
features to be exploited as a control for the experimental errors of
DNA amplification and sequencing. The working hypothesis is
that by comparing the mutability of UCRs with that of
genomically unstable regions, the higher mutation rate of the
latter should become eventually detectable. This model works only
under two assumptions. The first one is that UCRs are conserved,
not only in germline, but also in somatic cells. Recently, an altered
expression of some UCRs has been reported in leukaemia and
carcinomas [17], and two out of six SNPs that are present in
UCRs show significant association with familial breast cancer risk
[18]. Both these studies suggest that UCRs may play a role also in
adult cells, and therefore, they might be under somatic selection.
The second assumption is that the cancer mutation rate is higher
or at least comparable to the experimental error rate, because only
in this case can the difference in mutability be appreciated. This
seems a plausible assumption, given the current estimations for the
cancer-associated mutator phenotype [10,11].
As a proof of principle of this analytical approach, we
resequenced more than 45,000 distinct DNA filaments of an
,1,500-bp genomic segment centred on a carefully selected UCR.
The region derived from three different tissues of patients affected
by HNPCC: neoplastic colon mucosa, nonneoplastic colon mucosa,
and peripheral blood. As a negative control, we used the peripheral
blood of nine healthy donors. To amplify and sequence each
sample, we used emulsion PCR followed by pyrosequencing [19].
This method offers, to date, the best compromise between
sufficiently long reads and low error rate in miscalled bases [20].
Thedepthofcoveragethatwereached allowedustodetectgenomic
instabilityinneoplasticaswellasinnonneoplasticHPNCCsamples,
offering the first, to our knowledge, evidence of constitutional
genomic instability of these individuals.
Results
UCR Selection, Amplification, and Sequencing
Starting from 481 UCRs [12], we restricted the analysis to the
307 regions detectable in seven fully sequenced vertebrates
(human, mouse, rat, cow, chicken, frog, and fugu). We enlarged
all UCRs in both directions to allow the inclusion of nonconserved
sequences. The resulting extended UCRs (eUCRs) were composed
of the ultraconserved core and nonconserved flanking regions. All
307 eUCRs were screened for genomic and functional properties
that would favour the detection of a difference in mutability
between the ultraconserved core and the flanking segments (Table
S1). The best candidate was eUCR41, a 1,493-bp-long region
centred on a 217-bp-long ultraconserved core (Figure 1A). This
extended region bears two SNPs frequent in the European
population, has no coding activity, and is located in a gene desert.
Although the role of UCR41 is unknown, it has been reported to
drive gene expression in the mouse embryo [21] and might be
transcribed in adult cells [17]. We verified that homopolymers in
eUCR41 are shorter than 10 bp and contribute for only a small
portion of the entire region (,8.2%). In addition, the base
composition is similar inside and outside the ultraconserved core
(Figure 1B).
We extracted the DNA from the neoplastic colon mucosa,
nonneoplastic colon mucosa, and peripheral blood of nine
HNPCC patients with known germline mutations in either
MLH1 or MSH2 genes. All tumour samples, six adenocarcinomas,
and three adenomas, were verified to display high degree of MSI
(Table S2). As a negative control, we used the peripheral blood of
nine healthy donors. To amplify eUCR41, we divided the region
into 11 overlapping segments (Figure 1A) and reduced the PCR
errors by using the highest fidelity DNA polymerase available to
date [22]. To uniformly cover the region and minimize the
contribution of single individuals, we pooled equimolar ratios of all
amplicons from the different tissues types of each individual into
four distinct samples: cancer colon (CC), nonneoplastic colon
(NC), peripheral blood leukocytes (PBL), and healthy peripheral
blood leukocytes (H-PBL). Each sample was sequenced on both
sides using a fully dedicated run of ultradeep pyrosequencing [19].
This allowed sequencing of more than 83 million single bases per
sample, corresponding to an average coverage of more than
45,000 reads/base pair (Figure S1, Table 1). After aligning all
obtained reads to the reference sequence, we measured the
substitution frequency at each position, defined as the percentage
of reads bearing a nucleotide different from the reference. We
distinguished between high (.0.1%) and low (,0.1%) frequency
substitutions (Table 1), according to the estimated detection power
of the method [23,24].
Analysis of High-Frequency Substitutions
After manual inspection, we discarded all but four high-
frequency substitutions (Table 1). Errors were mostly generated by
incorrect indels in proximity of polynucleotide stretches, often at
the end of the reads where the sequencing performance decreases
Author Summary
In hereditary non-polyposis colorectal cancer (HNPCC), a
germline mutation in one allele of a gene responsible for
repairing DNA damage predisposes the host to cancer,
because subsequent somatic inactivation of the one wild-
type allele leads to genomic instability that favours
tumourigenesis. Nonneoplastic tissues of HNPCC individ-
uals are believed to repair DNA normally, as they are
heterozygous and thus are thought to be genomically
stable. However, methods used to date are known to be
incapable of detecting very low levels of genome
instability. Here, we present a more sensitive procedure
based on the resequencing of a HNPCC genomic region
using next-generation sequencing technology. With this
approach, we show that genomic instability is in fact
detectable in nonneoplastic tissues of HNPCC patients
compared with healthy donors. This constitutional insta-
bility may predispose them to acquiring the second
somatic mutation event needed for cancer development.
Highly Sensitive Detection of Genomic Instability
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the reference sequence, which resulted in false substitutions
(Figure S2).
Of the four high-frequency mutations that passed the manual
inspection, two are the known SNPs detectable in all four samples
and two are G:C to A:T clonal somatic transitions only present in
sample CC (Figure 2A). We genotyped eUCR41 in all analyzed
individuals (Table S4) and confirmed that the minor allele
frequency (MAF) of the two SNPs obtained with 454 sequencing
was comparable with that inferred from Sanger sequencing
(Table 2). This confirms that amplicons from the nine individuals
were pooled in equimolar ratios in all four samples and that all of
them contributed uniformly to the results. Sanger sequencing also
showed that the two somatic mutations are detectable in
heterozygosis in two different patients (patients 5 and 6, Table
S4). From the substitution frequency obtained from pyrosequencing
(Table 2), we could infer that mutations 871 and 1,095 occur in
37.0% and 23.4% of the corresponding PCR products, respectively.
Consideringthat bothareheterozygous,thesemutationsarepresent
in about 74% and 47% of the diploid cancer genomes of patients 6
and 5, respectively. They therefore reflect the expansion of the
dominant neoplastic clones. Further experimental validations are
needed to assess whether these two clonal mutations are driver or
passenger.Thefact thatbothcorrespond tothewild-type nucleotide
in mouse (A:T) suggests that they might be tolerated, and hence
hitchhiked, during clonal expansion.
Because indels at homopolymers are a major source of
sequencing errors in the 454 platform ([20] and Figure S2), we
ignored this type of modification in our analysis. Despite the high
Figure 1. Features of eUCR41. (A) Genomic coordinates refer to the
hg18 assembly of the human genome. The two grey bars correspond to
the extremely conserved sequence [58], and to the genomic region
tested for possible enhancer activity [21], respectively. Black bars
indicate the 11 overlapping segments used for the amplification. (B)
Percentage of homopolymers and base composition of eUCR41, of the
ultraconserved core, and of the flanking regions are shown.
doi:10.1371/journal.pbio.1000275.g001
Table 1. Results of the ultradeep sequencing screening.
Sample Total Reads Total Bases
Average Read
Length (bp)
Aligned
Reads
Positions with High Substitution
Frequency (.0.1%)
Positions with Low Substitution
Frequency (,0.1%)
SNPs Clonal Mutations Errors
CC 460,584 89,958,949 195.3 99.8% 2 2 20 1,221
NC 429,940 83,376,393 193.9 98.9% 2 0 18 1,215
PBL 496,358 96,210,962 193.8 99.8% 2 0 35 1,151
H-PBL 459,691 88,625,322 192.8 99.4% 2 0 38 1,157
For each sample, the total number of sequence reads and sequenced bases are shown, together with the average length of the reads and the percentage of reads
aligned to the reference sequence. The latter correspond to the fraction of reads that passed the quality filter of 454 sequencing. Reported also are the positions of
eUCR41 with substitutions at high (.0.1%) and low (,0.1%) frequency. The threshold of 0.1% represents the detection power of 454 sequencing.
doi:10.1371/journal.pbio.1000275.t001
Figure 2. Mutation spectrum of eUCR41 in sample CC. (A) All
detected substitutions are mapped on the corresponding positions of
eUCR41. Two ranges of substitution frequency are shown: 40.5%–2.5%
and ,1.0%, since no substitution was detected in the range 2.5%–1.0%.
All substitutions reported in the range 1.0%–0.1% were manually
checked and excluded as sequencing errors. (B) Mutability was
calculated using sliding windows of the same length as UCR41. Values
corresponding to the middle point of each window are reported.
Mutability increases with the decrease of sequence conservation: it is
always below average for sequence identity .50%, whereas it is above
average for nonconserved segments. Similar trends were observed for
all samples deriving from HNPCC (unpublished data).
doi:10.1371/journal.pbio.1000275.g002
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eUCR41 are significantly more instable in the HNPCC samples
than in the healthy control (Table S5).
Instability of HNPCC Neoplastic and Nonneoplastic
Genome
Low-frequency substitutions (,0.1%) likely consist of an
indistinguishable mixture of nonclonal true mutations and errors
that have been introduced during DNA amplification and
pyrosequencing. Similarly to what we did for high-frequency
substitutions, we excluded indels from the analysis to reduce the
impact of 454 sequencing errors. The pattern of these
substitutions is different, and their frequency is lower (Table
S6) than the recently estimated contribution of PCR errors [25].
This is likely due to the fact that we used the polymerase with the
lowest error rate compared to all other thermostable polymerases
with 39-59 proofreading activity [22,26,27]. We used all low-
frequency substitutions to measure the mutability of eUCR41,
defined as the substitution frequency over the entire region (see
Materials and Methods). To verify whether UCR41 is conserved
also in cancer cells, we dynamically scanned the mutability
within eUCR41 using sliding windows as long as UCR41.
Whereas nonconserved segments of eUCR41 always show
mutability higher than average, mutability decreases for
increasing values of sequence conservation and reaches the
minimum in correspondence of the ultraconserved core
(Figure 2B). To assess the significance of the inverse correlation
between mutability and sequence conservation, we compared the
distribution of substitution frequency within the ultraconserved
core with that of the flanking regions. We found that the two
distributions differ significantly in neoplastic and nonneoplastic
HNPCC samples, but not in healthy donors (Table 3). To
exclude a possible bias due to the differences in length and,
although minimal (Figure 1B), in base composition between
UCR41 and its flanking segments, we measured the mutability
ratio (m) between flanking regions and UCR41 in all four
samples. Each observed value was then compared to the
expected distribution of mutability ratios after 1,000,000 random
permutations. This comparison showed that base substitutions
occur significantly more frequently in the flanking regions than
in the ultraconserved core in all HNPCC samples but not in
healthy donors (Figure 3).
Table 2. MAF of the high-frequency mutations in eUCR41.
Mutation MAF in HNPCC Patients MAF in Healthy Donors
Sample CC (454) Sample NC (454) Sample PBL (454) Sanger Sample H-PBL (454) Sanger
SNP 286 (A/G) 13.7% 10.6% 12.0% 11.1% 4.5% 5.5%
SNP 1204 (A/G) 40.0% 42.0% 38.0% 38.9% 32.6% 33.3%
MUT 871 (G/A) 4.1% — — — — —
MUT 1095 (G/A) 2.6% — — — — —
For both SNPs and somatic mutations (MUT), the MAF in all samples is reported, as derived from 454 and Sanger sequencing. In the case of 454, MAF was calculated as
the percentage of reads bearing the minor allele in each sample. In the Sanger screening, it corresponds to the fraction of minor alleles detected in the nine patients
and in the nine healthy donors. Sanger genotyping confirmed that the two clonal mutations in sample CC are heterozygous mutations present in two different patients.
Combining this information with the frequency in the 454 screening, it is possible to infer that these mutations are present in about 74% and 47% of the cells of the two
patients, respectively.
doi:10.1371/journal.pbio.1000275.t002
Table 3. Substitution frequency and mutability outside and inside UCR41.
Sample All Data Data after Removing Potential Errors
Positions with Low
Substitution Frequency
Median Substitution
Frequency (610
23) p-Value
Positions with Low
Substitution Frequency
Median Substitution
Frequency (610
23) p-Value
Outside Inside Outside Inside Outside Inside Outside Inside
CC 1,044 177 7.98 5.85 3610
27a 729 115 9.11 7.23 7610
24a
2610
27b 4610
24b
NC 1,038 177 8.38 7.14 6610
25a 704 131 9.21 7.24 6610
25a
3610
25b 3610
25b
PBL 979 172 7.82 5.28 8610
27a 655 114 8.73 6.95 5610
25a
4610
27b 3610
25b
H-PBL 985 172 10.35 8.14 0.09
a 672 111 10.85 10.34 0.99
a
0.05
b 0.50
b
For each sample, the number of positions with low substitution frequency and the median substitution frequency outside and inside UCR41 are reported, considering
all data and after removing potential errors. At such a low substitution frequency, it is not possible to directly compare substitution frequencies between different
samples because of the high contribution of run-specific errors. When the distributions of substitution frequency outside and inside UCR41 are compared in each
sample, it becomes clear that they differ significantly in all three HNPCC samples, but not in H-PBL.
aTwo-tailed Wilcoxon test.
bOne-tailed Wilcoxon test (alpha value=0.05).
doi:10.1371/journal.pbio.1000275.t003
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Because we rely on low-frequency substitutions for estimat-
ing genomic instability, it is instrumental to control for possible
sources of noise that could invalidate our results. We therefore
reanalysed the data after filtering for typical errors of the 454
p l a t f o r m .F i r s t ,w er e m o v e da l l stretches of homopolymers
(n.3) and two flanking bases on both sides, which are known
to accumulate pyrosequencing artefacts [25]. Second, we
removed all reads hosting at least one uncalled base, since
they are prone to errors [28]. Finally, we discarded all
substitutions occurring only in one read, which bear most
random errors [24]. After removing all potential errors, the
difference in substitution frequency (Table 3), as well as in
mutability (Figure 3) between outside and inside UCR41
remains significant in all HNPCC samples and not significant
in H-PBL. The same holds true when we applied the three
filters separately (Table S7).
Although we used the highest fidelity polymerase, we further
controlled whether PCR errors could have any impact on our
results. We estimated that ,12%–15% of low-frequency substi-
tutions could be errors introduced by the DNA polymerase. After
randomly removing a comparable fraction of substitutions in all
four samples, we again observed higher mutability outside than
inside UCR41 in HNPCC and no difference in H-PBL (Table S8).
This test clearly excludes that PCR errors impacted in a significant
manner on the observed difference in mutability between the
UCR core and its flanking regions.
Direct Comparison of HNPCC and Healthy Samples
Due to the occurrence of run-specific errors in the 454 platform
[29], substitution frequencies of different samples cannot be
compared directly. Instead of substitution frequencies, we
compared the mutability ratios, which exploit the ultraconserved
element to normalize the sample-specific errors. In particular, we
compared the observed difference in mutability ratio between each
of the HNPCC samples and H-PBL with the corresponding
expected distribution. Also in this case, we performed 1,000,000
random permutations to compute expected differences in
mutability ratios. In all three comparisons, the difference in the
mutability ratio was significantly higher than expected using both
raw and filtered data (Figure 4). This result provides further
evidence that both neoplastic and nonneoplastic tissues from
HNPCC patients accumulate more mutations than tissue from
healthy individuals.
Altogether, our data verify our initial assumption that UCR41 is
maintained ultraconserved also in somatic cells, and it can be
therefore used to normalize the experimental errors. At deep
coverage, the mutation rate of the HNPCC genome allows
detection of an increased occurrence of mutations in the flanking
segments when compared to the ultraconserved core. No increase
is detectable in the sample H-PBL, although UCR41 is very likely
also to be conserved there. In this case, the mutation rate of the
healthy human genome is so low that sequencing errors overcome
true mutations in the entire region. The different behaviour
between HNPCC and healthy samples becomes more evident
when the contribution of random errors decreases. When we
removed positions with substitutions at increasing values of
frequency, the mutability ratio increases in all HNPCC samples,
but not in H-PBL, where it is always around 1 (Figure 5). This
result also excludes that the mutability ratio of the normal sample
is due to a casual and nonhomogenous distribution of low-
Figure 3. Observed and expected mutability outside and inside
UCR41. Observed values of mutability ratios (arrows) were compared
to the expected distributions computed from 1,000,000 random
permutations of the raw data (red) and after removing all potential
errors (blue). p represents the probability of obtaining the observed
mutability ratio by chance and was calculated as the fraction of the
expected ratios equal or higher than the observed value.
doi:10.1371/journal.pbio.1000275.g003
Figure 4. Difference in mutability ratio between HNPCC and healthy samples. The observed difference in mutability ratios (arrows)
between each of the three HNPCC samples (mCC, mNC, and mPBL) and the healthy control (mH-PBL) were compared to the corresponding expected
distributions. These were computed from 1,000,000 random permutations of the raw data (red) and after removing all potential errors (blue). p
represents the probability of obtaining the observed difference in m by chance and corresponds to the fraction of the expected differences equal or
higher than the observed value.
doi:10.1371/journal.pbio.1000275.g004
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flanking segments.
Sensitivity and Specificity in Detecting Rare Substitutions
In order to experimentally assess the error rate associated with
pyrosequencing, we performed a controlled dilution experiment in
which an amplicon carrying a single mutation (G, corresponding
to the SNP at position 1,204, Figure 1A, Table S4) was diluted
with the corresponding wild-type amplicon (A). At each step of the
four controlled dilutions (1:1,000; 1:2,000; 1:5,000; and 1:10,000),
wild-type and mutant amplicons were first quantified separately to
control for experimental inaccuracy and then pooled. The four
samples were sequenced using four distinct lanes. Although the
expected coverage was 70,000 reads/lane, we obtained around
double the amount of reads for each sample, which indicates an
optimal experimental setting (Table 4). By plotting the observed
frequency of the mutated allele against the corresponding dilution,
we observed a strict linear correlation (R
2.0.99) also for the most
extreme dilution (Figure S3 and Table 4). This result assesses the
high sensitivity of our procedure in detecting very rare mutations.
The dilution experiment also allows an estimation of specificity,
defined as the fraction of correct positions over the total sequenced
positions. In the sequenced region, specificity starts to decrease for
substitution frequencies lower than 0.05% (Table 4). Since
specificity depends on the sequence composition and complexity,
it is reasonable to think that the lower bound of specificity is
different for longer and more complex regions. This supports the
mandatory usage of an internal normalization of the experimental
error, when substitutions at very low frequency are considered.
Interestingly, the few positions with substitution frequency
between 0.1% and 0.05% (less than 18 in all four samples)
show an overall frequency higher in sample CC than in sample
H-PBL, also without using UCR41 as an internal control
(p-value=8610
23, Wilcoxon text). This again confirms that the
signal improves by removing random errors (Figure 5).
Discussion
We exploited the frozen status of UCR41 to increase sensitivity
and specificity of ultradeep sequencing and hence quantify cancer-
associated genomic instability. The obtained results offered several
insights into cancer genetics. We provided the first indication that
an ultraconserved element does not accumulate mutations in
somatic cells also in conditions of genomic instability. This result
suggests that genomic instability is not constant in all regions of the
cancer genome and that certain genomic portions are utterly
preserved from modifications even in advanced tumoural stages
such as carcinoma. It remains to be verified whether all UCRs are
under the same somatic conservation and which are the reasons
for it. In the case of UCR41, the extreme conservation could be a
sign of strong purifying selection. UCR41 seems to be involved in
a variety of different functions. It drives the expression of reporter
gene in mouse embryos, [21], and gets transcribed into noncoding
RNAs in adult tissues [17]. In addition, UCR41 is located
upstream to PROX1, a gene that acts as a tumour suppressor in
breast and pancreatic cancers [30,31], hepatocellular carcinomas
[32] and lymphomas [33]. Recently, PROX1 has been shown to
promote tumour growth and malignant progression in colorectal
cancers [34]. Finally, the region between UCR41 and PROX1 can
undergo genomic rearrangements that have been associated with
heart defects [35]. Altogether, these observations may indeed
indicate that UCR41 is under functional constraints in both
germline and somatic cells, although the alternative hypothesis of
UCR41 as a cold spot for mutations, as proposed for other UCRs
[14], cannot be completely ruled out. Whatever the biological
reason for the somatic conservation of UCR41 may be, we proved
that it can be used as an internal control for the sequencing errors,
thus increasing the sensitivity in the detection of genomic
instability.
Figure 5. Variation of the mutability ratio for decreasing
contribution of random errors. By progressively decreasing the
number of positions with rare substitutions, the mutability ratio (m)
outside and inside UCR41 increases in all samples from HNPCC patients.
In H-PBL, errors overcome true mutations inside and outside UCR41 at
any value of frequency cutoff. The corresponding mutability ratio is
therefore always around 1. Values on the y-axis correspond to the
observed ratio for each sample.
doi:10.1371/journal.pbio.1000275.g005
Table 4. Sensitivity and specificity in detection of rare mutations.
Dilution Total Reads
Mutated Reads
(G)
Observed Frequency
(%G)
Expected Frequency
(%G)
Positions with
Errors Specificity
1:1,000 151,118 110 0.073 0.1 0 1.00
1:2,000 148,990 56 0.038 0.05 0 1.00
1:5,000 144,307 30 0.021 0.02 6 0.96
1:10,000 161,921 19 0.012 0.01 24 0.85
For each dilution value, the total number of sequenced reads, the number of reads bearing the mutated allele (G), and the observed and expected substitution
frequency are reported. We considered errors all positions showing a substitution frequency equal to or higher than the corresponding frequency of the mutated allele.
This allowed measuring of the specificity, defined as the number of true negatives (1562errors) over all variable positions (156).
doi:10.1371/journal.pbio.1000275.t004
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genome of nonneoplastic HNPCC cells has a constitutional
mutation rate higher than MMR proficient genomes and,
therefore, it is deficient in repairing DNA (Figure 4). Despite
sporadic reports of low-frequency MSI [36,37], HNPCC
nonneoplastic cells are commonly assumed to repair DNA
normally [38,39]. This was based on measures of genomic
instability that required the presence of clonal mutations. These
assays were able to detect instability in tumoural samples, but not
in pretumoural stages in which cells do not have a clonal origin.
Indicative of the difference between the two approaches is the
observation that several thousands of different clones are needed
to reproduce the data reported here, with the concrete possibility
of cloning PCR errors. The constitutional instability of MMR
+/2
genomes implies that they start accumulating low-frequency
substitutions before cancer transformation. This constitutional
instability could predispose MMR
+/2 individuals to the inactiva-
tion of the second allele, which is a mandatory step to initiate
carcinogenesis [38,39]. Known mechanisms of somatic inactiva-
tion of the MMR wild-type allele include loss of heterozygosity
(LOH), promoter hypermethylation and somatic mutations in the
gene sequence. The relative contribution of these three main
mechanisms is controversial. In general, LOH seems the most
common, with a frequency that ranges from 33% to 86% of the
cases [40–46]. Although more rarely, somatic inactivating
mutations have also been reported [4,42,43,46–50]. In addition,
there are a number of cases in which none of the known
inactivating mechanisms can explain MMR deficiency [46,47]. A
constitutional mutation rate higher than healthy genome could
contribute to an explanation of those cases, because deleterious
mutations could directly hit the gene sequence, as well as other
regions important, for example, for the regulation of gene
expression. Our findings highlight the importance of an early
diagnosis of genomic instability for selecting the best clinical
approach to monitor, prevent, and possibly slow down the
progression to cancer. A molecular test to reveal cancer
predisposition could also restrict invasive surveillance examina-
tions, such as colonoscopy and/or extracolonic screening of
endometrium and ovary, only to positive carriers. To date,
predisposition testing in family members with the Lynch
syndrome consists of genetic screening of the MMR genes to
identify germline mutations [51,52]. Our strategy constitutes the
proof of principle to implement an alternative test for diagnosing
cancer predisposition without any a priori knowledge of the
mutated genes. Although promising, several aspects of our
procedure need further investigation. It remains to be confirmed
whether MMR
+/2 genomes of healthy carriers, (i.e., gene carriers
who had not developed cancer yet) are unstable as well. So far, we
have only analyzed nonneoplastic cells of HNPCC patients, which
constitutes reliable, but indirect, evidence that this could indeed
be the case. In addition, although the MAF inferred with Sanger
was comparable with that obtained with 454 sequencing (Table 2),
we cannot exclude that the mutation rate is variable even between
individuals and not only between HNPCC carriers and healthy
donors. We therefore need to measure genomic instability of
single individuals to check for possible interindividual variability,
DNA quality, and other technical factors, as well as to confirm the
suitability of our approach as a genetic marker.
Materials and Methods
Ethics Statement
All individuals involved in this study agreed to and signed the
informal consent form for the use of their biological samples for
research purposes, approved by the local ethical committee in
accordance with current Italian regulations.
UCR Selection
The genomic coordinates of 481 UCRs were derived from
the hg18 release of the human genome (March 2006). The
conservation between each human UCR and the corresponding
orthologous element in mouse (February 2006), rat (November
2004), dog (May 2005), cow (March 2005), chicken (February
2004), and fugu (August 2002) was derived from the multiZ
alignments [53]. Only 307 UCRs detectable in all seven species
were retained for further analysis. These UCRs were extended on
both sides up to 50% of sequence conservation, measured as the
percentage of nucleotides over a 25-bp sliding window conserved
in at least four of the seven species. To include also nonconserved
segments, regions were further extended 500 bp on both sides.
The selection of extended UCR41 (eUCR41) as the best candidate
for ultradeep sequencing was done as reported in Table S1. The
entire sequence of eUCR41 was divided into 11 overlapping
segments (amplicons), each around 200-bp long. For each
amplicon, a pair of forward and reverse primers was designed
with 40%–60% of GC content and a melting temperature of
58–60uC. The UCSC in silico PCR tool was used to check that
selected primers did not have spurious additional matches on the
human genome. All primers were fused with ad-hoc 59 overhangs
to allow emulsion PCR and sequencing.
Sample Preparation and Sequencing
Nine HNPCC carriers were selected from the Registry of
Hereditary Colorectal Cancer at the Istituto Nazionale Tumori
(Milan, Italy). Heterozygous MLH1 and MSH2 mutations were
detected on genomic DNA purified from peripheral blood
leukocytes [54]. Nine healthy controls more than 50 years old
(four males and five females) were selected among blood donors
with Italian ancestry and no personal history of cancer.
Tumours (six adenocarcinomas and three adenomas) and
normal colonic mucosa were surgical removed and cryocon-
served. Hematoxylin-eosin staining revealed that tumour areas
were not heavily contaminated with normal cells, did not
present necrosis, and that normal colonic mucosa was free of
tumour infiltration. Tumour and matched normal DNAs were
amplified by PCR using fluorescent primers followed by gel
electrophoresis on a 3130 DNA Sequencer (Applied Biosystems)
and fragments were analyzed using GeneScan and Genotyper
software [55]. All tumour samples used for the analysis showed
altered electrophoretic pattern in tumour compared with
normal DNA for at least two microsatellites of the National
Cancer Institute–recommended panel [56]. Genomic DNA was
extracted from frozen tumours and normal mucosa using the
QIAmp DNA Mini Kit and from PBL using the QIAmp DNA
Blood Mini Kit (Qiagen) according to the manufacturer’s
instructions. Genomic DNA was amplified by PCR using the
high-fidelity Pwo SuperYield DNA Polymerase (Roche). The
PCR products were individually checked on agarose gel and
purified using the AGENCOURT AMPure kit (Beckman
Coulter) according to the manufacturer’s protocol. All 99
amplicons from each tissue type (CC, NC, PBL, and H-PBL)
were quantified using NanoDrop ND-1000 UV-Vis Spectro-
photometer and pooled in equimolar ratio to obtain four
samples (CC, NC, PBL, and H-PBL). Four independent runs of
pyrosequencing were performed at 454 Life Sciences, each of
them on a 70675-mm PicoTiterPlate using the GS FLX
Sequencer. Emulsion PCR and sequencing were performed as
previously described [19]. Each sequence read was base called
Highly Sensitive Detection of Genomic Instability
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reference sequence as previously described [23]. Sanger
sequencing was performed to characterize the genotype of each
individual in each tissue and to identify the carriers of the two
mutations in cancer. Amplicons were generated using the Pwo
SuperYield DNA polymerase (Roche) and sequenced in both
directions on a 31306l sequencer, Data Collection 3.0 (Applied
Biosystems), using the dRhodamine chemistry under standard
conditions.
Measures of Substitution Frequency, Mutability, and
Mutability Ratio
For each position of eUCR41, the number of reads bearing a
nucleotide different from the reference sequence was counted. The
substitution frequency at position j was defined as:
nj=tj
  
|100
where n is the number of reads differing from the reference, and t
is the total number of reads for position j. Positions with high
substitution frequency (.0.1%) in all four samples were manually
checked to reject possible false positives. In the analysis of positions
with low substitution frequency (,0.1%), only base substitutions
and no indels were considered to reduce the probability of
pyrosequencing artefacts associated to insertions and deletions.
Substitution frequency outside and inside UCR41 was compared
using the Wilcoxon test.
The mutability of eUCR41 as well as of specific regions (i.e.,
ultraconserved core; flanking segments; 217-bp-long sliding
windows) was defined as:
X jzL{1
i~j
ni=
X jzL{1
i~j
ti
 !
|100
where j is the starting position and L is the length of the region.
Mutability ratio (m) was calculated as the ratio between mutability
outside and inside UCR41:
(
X 653
i~21
niz
X 1455
i~871
ni)=(
X 653
i~21
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X 1455
i~871
ti)
"#
outside
=
X 870
i~654
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To account for the putative effects of length and base
composition on the mutability of UCR41 and flanking segments,
a permutation test was performed in which all positions with low-
frequency substitutions were randomly reassigned in each sample,
keeping the same length base composition of the two regions.
Permutations were repeated 1,000,000 times, and the ratio
between the expected mutability outside and inside UCR41 was
calculated at each round. The probability (p) of observing the
experimental ratio by chance was calculated as the fraction of the
expected ratios equal or higher than the observed value.
The three null distributions to test the difference of mutability
ratio between cases (samples CC, NC, and PBL) and control
(sample H-PBL) were also computed using a permutation test. For
each comparison, all sequence positions were randomly reassigned
for 1,000,000 times, again maintaining length and base compo-
sition of UCR41 and flanking regions. At each permutation, the
difference in the mutability ratio was derived, and each expected
distribution was compared to the corresponding observed
difference.
Estimation of PCR Errors
The number of possible errors introduced by the DNA
polymerase during the polymerase chain reaction (PCR errors),
was first estimated and then removed from experimental data.
PCR errors were quantified using two different approaches. The
first one was based on the binomial probability distribution, in
which the number of PCR errors X was considered a random
variable that follows a binomial distribution:
X*B(L,p)
where L is the length of the region, and p is the probability to
accumulate errors at a given position after d duplications with a
given number of errors r introduced per base pairs at each
duplication:
p~1{(1{r)
d
From this model, the total number of PCR errors expected in a
region L is:
E(X)~
X L
k~0
k
L
k
  
pk(1{p)
n{k
The total number N of PCR errors present in n single-stranded
DNA sequences will be:
N~E(X)n=2
In our analysis, parameters r, d, L, and n were all derived from
the experimental data. The applied error rate was r=6.5610
27
errors/base pair/duplication [22,57]. The number of duplications
was set equal to the number of PCR cycles d=40. The length L of
the region was calculated as the number of positions unchanged or
bearing low-frequency substitutions in each sample (1,431; 1,435;
1,418; and 1,415 in CC, NC, PBL, and H-PBL, respectively). The
number n of single-stranded DNA sequences was taken from the
number of reads of each sample (49,194; 45,383; 53,212; and
49,005 in CC, NC, PBL, and H-PBL, respectively). In the second
approach, the cycles of PCR amplifications were simulated in
silico using a model similar to that used for the mutation rate.
Starting from one DNA double strand of length L, errors were
randomly introduced at a rate r in each position of the strand at
each of the d PCR cycles. Once introduced, errors were retained in
all the daughter strands. At the end of the amplification, the
number of PCR errors present in the n single strands of DNA
sequences was derived. The procedure was reiterated 1,000 times
to generate a distribution of N values. The number of estimated
PCR errors returned by the two approaches is identical and is
reported in Table S8.
To verify the putative effect of PCR errors on the difference in
mutability originally detected between the UCR core and the
flanking regions, a number of low-frequency substitutions equal to
the estimated number of PCR errors in each sample was randomly
removed. The procedure was repeated 1,000 times, and the
distribution of observed mutability ratios between the flanking
regions and the UCR core was derived. Applying the same
permutation used for the real samples, the distribution of expected
ratios was also derived. The results of both simulations are
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between observed and expected distributions.
All statistical analyses were performed using the R statistical
environment and ad hoc Perl scripts.
Serial Dilution
Dilution experiments were performed using the 157-bp-long
segment of eUCR41 corresponding to amplicon 9, which bears
a SNP in position 1,204 (SNP A/G, Figure 1A). This segment
was amplified from the blood of two healthy donors showing
homozygous AA and GG genotypes, respectively (Samples 13
and 14, Table S4). After amplification, the regions were purified
as described above and pooled in different relative amounts.
Four final dilutions were obtained with decreasing G:A ratios
(1:1,000; 1:2,000; 1:5,000; and 1:10,000; respectively). To
correct for possible experimental inaccuracies during DNA
quantification and pipetting, at each step of the serial dilutions,
DNA quantifications of the two alleles were performed using the
Victor PicoGreen fluorometer (PerkinElmer Life Sciences). The
obtained values were used to calibrate the successive dilution.
The DNA samples corresponding to the four dilutions were
sequenced using four distinct lanes using a four-lane gasket for
70675 PicoTiterPlate device on the GS FLX Sequencer at
BMR Genomics. Specificity was measured as TN/(TN+FP).
The number of true negatives (TN) was calculated as the
number of correctly sequenced positions, i.e., positions with no
errors at a frequency equal or higher than the frequency of the
diluted allele.
Supporting Information
Figure S1 Depth of coverage reached with the sequenc-
ing screenings. For each sample, the coverage of sequencing
(reads/base pair) was measured. The average coverage is 49,150 in
sample CC; 45,370 in sample NC; 52,530 in sample PBL; and
48,380 in sample H-PBL. Regions in which the coverage almost
doubles correspond to overlapping segments between contiguous
amplicons (see Materials and Methods and Figure 1A). Colour
gradient corresponds to the degree of sequence conservation, as
reported in Figure 1A. UCR41 is highlighted in green.
Found at: doi:10.1371/journal.pbio.1000275.s001 (6.29 MB TIF)
Figure S2 Examples of high-frequency errors. For each of
the four hot spot regions described in Table S3, a different
example of high-frequency errors derived from sample CC is
shown. In all cases, the errors are due to indels that cause
misalignments between the reads and the reference sequence. In
three cases, the misaligned region corresponds to the end of the
reads (*). (A) Reference position 1,050–1,061, frequency 0.1%. (B)
Reference position 633–652, frequency 0.6%. (C) Reference
position 1,071–1,094, frequency 0.1%. (D) Reference position
29–45 frequency 0.1%.
Found at: doi:10.1371/journal.pbio.1000275.s002 (0.62 MB TIF)
Figure S3 Sensitivity In detecting rare mutations. Serial
dilution of amplicon 9 bearing a SNP in position 1,204 (G,
Figure 1A) to the corresponding wild-type amplicon (A). The
linear regression curve was calculated by plotting the observed
frequency of the mutated allele G for a series of dilutions into the
corresponding A wild-type allele. A strict linear correlation is
maintained between observed and expected substitution frequency
also for allele frequency of 0.01% (dilution 1:10,000).
Found at: doi:10.1371/journal.pbio.1000275.s003 (0.13 MB TIF)
Table S1 Criteria for the selection of eUCR41 for
ultradeep sequencing. Shown are the genomic and functional
features, the reasons why they are important for the selection of
the best eUCR, the detection methods, and the corresponding
properties of eUCR41, the selected candidate. CEU, Utah
residents with ancestry from northern and western Europe;
dCNE, duplicated conserved noncoding elements.
Found at: doi:10.1371/journal.pbio.1000275.s004 (0.07 MB
DOC)
Table S2 HNPCC samples used for the analysis. For
each HNPCC patient, sex, germline mutation, histological
properties, and level of microsatellite instability (MSI) are
indicated. Germline mutations are described following the
guidelines of the Human Genome Variation Society (http://
www.hgvs.org/mutnomen). MSI was assessed in both adenomas
and adenocarcinomas by checking for the presence of at least two
unstable microsatellite markers (BAT25 and BAT26) [1].
Found at: doi:10.1371/journal.pbio.1000275.s005 (0.05 MB
DOC)
Table S3 Manual inspection of positions with high-
frequency errors. For each type of error, the possible source, the
range of positions in the reference sequence, and resulting positions
with errors in all four samples are reported. Most sequencing errors
occur in close proximity of stretches of polynucleotides and result in
hot spots of false insertions and deletions (indels). Indels also cause
misalignments with the reference sequence, with consequent false
substitutions. Representative flowgrams are shown in Figure S2 for
allfour main error hot spots. In four positions, the sequencing errors
are due to miscalls. We considered them as false substitutions
because either they had similar substitution frequency in all four
samples (positions 116, 1,444, and 1,445), or they were present only
in one sequencing direction (position 345, present only in reverse
amplicons). In these cases, we do not show any flowgram because
they are not explicative of the error type.
Found at: doi:10.1371/journal.pbio.1000275.s006 (0.05 MB
DOC)
Table S4 Genotyping and confirmation of high-frequen-
cy mutations. For both HNPCC patients (1–9) and healthy
donors (10–18), the corresponding genotype of SNPs and somatic
mutations in eUCR41 is reported in each analysed individual, as
detected by Sanger sequencing. The genotype was used to
measure the minor allele frequency (MAF), defined as the
frequency of the rare allele over the total. The similar values of
the MAFs obtained with Sanger and with 454 sequencing allowed
us to confirm that the samples used in this study were pooled in
equimolar ratios (Table 2). Clonal somatic mutations in sample
CC of patients 5 and 6 are reported in red, whereas the individuals
used for the dilution series are shown in blue. Blood of patient 1
was not available for further analysis.
Found at: doi:10.1371/journal.pbio.1000275.s007 (0.10 MB
DOC)
Table S5 Rate of indels at homopolymers in the four
samples. The percentage of reads with indels of at least 1 bp in
the homopolymeric tract is reported for the two 9-bp-long polyAs
in each sample.
Found at: doi:10.1371/journal.pbio.1000275.s008 (0.04 MB
DOC)
Table S6 Frequency and pattern of low-frequency
substitutions. For each type of substitution, the frequency was
calculated as the number of times that the substitution was
observed divided by the number of times that that position was
read.
Found at: doi:10.1371/journal.pbio.1000275.s009 (0.05 MB
DOC)
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mutability outside and inside UCR41 after filtering for
sequencing errors. Reported is the number of positions with
low substitution frequency (,0.1%) outside and inside UCR41 for
each sample, after three different filters for sequencing errors were
applied. After each filtering, the usual statistical analyses were
applied. In particular, the distributions of substitution frequency
outside and inside UCR41 were compared using the Wilcoxon
test, whereas the observed mutability ratio was compared to the
expected distribution after 1,000,000 random permutations (see
main text). *Two-tailed Wilcoxon test (alpha value=0.05).
**Probability of observing a mutability ratio equal or higher than
the observed value, after 1,000,000 random permutations.
Found at: doi:10.1371/journal.pbio.1000275.s010 (0.06 MB
DOC)
Table S8 Estimation of PCR errors. For each sample, the
total number of estimated PCR errors was derived using the
binomial probability distribution. Comparable numbers were
obtained using the simulation model (see text). The corresponding
percentage of PCR errors over the total low-frequency substitu-
tions (,0.1%) was calculated for raw data and after filtering for
potential sequencing errors. As expected, the percentage of PCR
errors increases after filtering for sequencing errors, since the
contribution of errors introduced by 454 sequencing decreases.
For observed and expected distributions of mutability ratios, the
mean, as well as 95% confidence interval (in brackets), are
reported. In each sample, observed and expected distributions
were compared using the Wilcoxon test.
Found at: doi:10.1371/journal.pbio.1000275.s011 (0.05 MB
DOC)
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